Inhibikase Therapeutics shares owned by Susquehanna International
Quarter-by-quarter ownership of Inhibikase Therapeutics (IKT) shares owned by Susquehanna International
from 13F filings
Historical chart of Susquehanna International investment in Inhibikase Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Inhibikase Therapeutics held by Susquehanna International consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Inhibikase Therapeutics by Susquehanna International
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $44k | 22k | 2.05 |
| 2025-09-30 | $74k | 46k | 1.62 |
| 2025-06-30 | $747k | 383k | 1.95 |
| 2025-03-31 | $1.1M | 505k | 2.19 |
| 2024-03-31 | $49k | 23k | 2.16 |